Michael A. Hast, PhD

Director, Scientific Strategy
Merz Pharmaceuticals, LLC

Poster(s):

• 1312 - Characteristics of incobotulinumtoxinA treatment for cervical dystonia in a real-world setting: dosing and muscles injected
  Thursday, February 27, 2025

  5:00 PM - 6:30 PM MST

• 1313 - Characteristics of incobotulinumtoxinA treatment for limb spasticity in a real-world setting: dosing and muscles injected
  Thursday, February 27, 2025

  5:00 PM - 6:30 PM MST